CTOs on the Move


 
Lygos employs cutting edge synthetic biology techniques to generate microbial catalysts to convert agricultural feedstocks into fine and commodity chemicals. Our robust high throughput screening and strain construction facilitates the rapid optimization of pathways to convert cheap and renewable feedstock to high value chemicals.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.lygos.com
  • 1249 Eighth Street
    Berkeley, CA USA 94710
  • Phone: 510.356.0555

Executives

Name Title Contact Details
Nicholas Ohler
Chief Technology Officer Profile

Funding

Lygos raised $15.5M on 07/17/2018

Similar Companies

Anixa Biosciences

Anixa is a publicly-traded biotechnology company developing a number of programs addressing cancer and infectious disease.

Quintiles

Quintiles is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Adolor Corporation

Adolor Corporation is a Exton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genera Energy

Genera Energy provides a robust and integrated biomass supply solution for the advanced biofuels, biopower, and biobased products industries.

Cadence Human Systems

Cadence Human Systems is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.